Cockroach allergens: Coping with challenging complexity - 04/04/19
Doi : 10.1016/j.jaci.2019.01.028
Jörg Kleine-Tebbe, MD a, ⁎ 
, Robert G. Hamilton, PhD b, Richard E. Goodman, PhD c
, Robert G. Hamilton, PhD b, Richard E. Goodman, PhD c a Allergy and Asthma Center Westend, Outpatient Department and Clinical Research Center Hanf, Ackermann & Kleine-Tebbe, Berlin, Germany
b Johns Hopkins Dermatology, Allergy and Clinical Immunology Reference Laboratory, Johns Hopkins Asthma and Allergy Center, Baltimore, Md
c Department of Food Science & Technology, University of Nebraska, Lincoln, Neb
∗Corresponding author: Jörg Kleine-Tebbe, MD, FAAAI, Allergy & Asthma Center Westend, Outpatient Clinic Hanf, Ackermann & Kleine-Tebbe, Spandauer Damm 130, Haus 9, D-14050 Berlin, Germany.Allergy & Asthma Center WestendOutpatient Clinic HanfAckermann & Kleine-TebbeSpandauer Damm 130, Haus 9BerlinD-14050Germany
Key words : Cockroach allergy, nonstandardized extracts, cockroach allergen components, allergen immunotherapy, diagnosis
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 4
P. 1342-1344 - avril 2019 Retour au numéro
Article précédent
- A burning need to redefine airways disease: Biomass smoke exposure identified as a unique risk factor for asthma–chronic obstructive pulmonary disease overlap in low- and middle-income countries
- Amir A. Zeki, Cameron H. Flayer, Angela Haczku
- Dominant negative CARD11 mutations: Beyond atopy
- Vivien Béziat, Emmanuelle Jouanguy, Anne Puel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?